X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (177) 177
alzheimer's disease (171) 171
neurosciences (156) 156
animals (142) 142
mice (127) 127
3xtg-ad mice (126) 126
a-beta (111) 111
mice, transgenic (105) 105
disease models, animal (95) 95
humans (84) 84
3xtg-ad (76) 76
alzheimers-disease (65) 65
male (63) 63
female (62) 62
alzheimer disease - pathology (59) 59
alzheimer disease - genetics (55) 55
alzheimer disease - metabolism (55) 55
brain (55) 55
mice, inbred c57bl (49) 49
amyloid beta-peptides - metabolism (48) 48
mouse model (45) 45
amyloid beta-protein precursor - genetics (44) 44
amyloid-beta (44) 44
analysis (42) 42
transgenic mice (40) 40
presenilin-1 - genetics (38) 38
tau proteins - genetics (38) 38
brain - metabolism (37) 37
tau (37) 37
alzheimer’s disease (36) 36
oxidative stress (34) 34
aging (32) 32
genetic engineering (31) 31
mild cognitive impairment (31) 31
neurology (31) 31
tau proteins - metabolism (31) 31
hippocampus (30) 30
memory (30) 30
pathology (30) 30
alzheimer disease - drug therapy (28) 28
brain - pathology (28) 28
article (27) 27
phosphorylation (25) 25
biochemistry & molecular biology (24) 24
cell biology (24) 24
dementia (24) 24
triple-transgenic model (24) 24
alzheimers disease (23) 23
geriatrics & gerontology (23) 23
cognitive ability (22) 22
rats (22) 22
amyloid beta-protein (21) 21
brain - drug effects (21) 21
hippocampus - metabolism (21) 21
transgenic mouse model (21) 21
alzheimer disease (20) 20
behavioral sciences (20) 20
estrogen (20) 20
in-vivo (20) 20
mutation - genetics (20) 20
neurodegeneration (20) 20
neurodegenerative diseases (20) 20
neurons - metabolism (20) 20
proteins (20) 20
rodents (20) 20
synaptic plasticity (20) 20
age (19) 19
age factors (19) 19
alzheimer disease - physiopathology (19) 19
amyloid (19) 19
amyloid beta-protein precursor - metabolism (19) 19
amyloid-β (19) 19
alzheimer disease - complications (18) 18
pharmacology & pharmacy (18) 18
tau protein (18) 18
3xtg-ad mouse (17) 17
amyloid precursor protein (17) 17
inflammation (17) 17
transgenic model (17) 17
3xtg-ad mouse model (16) 16
beta (16) 16
cognition (16) 16
cognitive impairment (16) 16
immunohistochemistry (16) 16
maze learning - drug effects (16) 16
neurons (16) 16
female 3xtg-ad mice (15) 15
long-term potentiation (15) 15
multidisciplinary sciences (15) 15
neurofibrillary tangles (15) 15
neuroprotection (15) 15
gene expression regulation - genetics (14) 14
peptide fragments - metabolism (14) 14
alzheimer disease - psychology (13) 13
amyloid beta (13) 13
animal models (13) 13
anxiety (13) 13
cells, cultured (13) 13
clinical neurology (13) 13
cognitive deficits (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Alzheimer's Disease, ISSN 1387-2877, 2011, Volume 24, Issue 3, pp. 421 - 454
Physical exercise is considered to exert a positive neurophysiological effect that helps to maintain normal brain activity in the elderly. Expectations that it... 
cognition | electrophysiology | gender | voluntary exercise | amyloid-β | PHF-tau | 3xTg-AD mouse | behavior | Alzheimer's disease | age | oxidative stress | RABBIT FOLLOWING STIMULATION | CONTROLLED-TRIAL | TRIPLE-TRANSGENIC MODEL | LONG-LASTING POTENTIATION | AMYLOID PRECURSOR PROTEIN | SYNAPTIC PLASTICITY | NEUROSCIENCES | amyloid-beta | MOUSE MODEL | A-BETA | COGNITIVE DEFICITS | Alzheimer Disease - complications | Age Factors | Glutathione - metabolism | Humans | Dark Adaptation - genetics | Conditioning, Operant - physiology | Male | Reflex, Startle - genetics | Electroencephalography | Glutathione Disulfide - metabolism | Body Weight - genetics | Alzheimer Disease - pathology | Brain - metabolism | Exploratory Behavior - physiology | Cognition Disorders - prevention & control | tau Proteins - genetics | Cognition Disorders - etiology | Amyloid beta-Peptides - metabolism | Physical Therapy Modalities | Female | Excitatory Postsynaptic Potentials - genetics | Disease Models, Animal | Neural Inhibition - genetics | Peptide Fragments - metabolism | Enzyme-Linked Immunosorbent Assay | Maze Learning - physiology | Acoustic Stimulation | Presenilin-1 - genetics | Mice, Transgenic | Mutation - genetics | Amyloid beta-Protein Precursor - genetics | Animals | Alzheimer Disease - rehabilitation | Brain - pathology | Exercise - physiology | Mice | Alzheimer Disease - genetics | Index Medicus
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 2012, Volume 30, Issue 4, pp. 943 - 961
Journal Article
Neurobiology of Disease, ISSN 0969-9961, 07/2019, Volume 127, pp. 264 - 277
Journal Article
Hippocampus, ISSN 1050-9631, 05/2018, Volume 28, Issue 5, pp. 358 - 372
Type 2 diabetes mellitus (T2DM) is an important risk factor for Alzheimer's disease (AD). Glucagon‐like peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic... 
p‐CAMKII | GLP‐1/GIP/Gcg triagonist | learning and memory | p‐GSK3β | long‐term potentiation | phosphorylated tau protein | amyloid‐β (Aβ) protein | p‐CREB | 3xTg‐AD mice | p-CAMKII | p-CREB | p-GSK3β | amyloid-β (Aβ) protein | 3xTg-AD mice | GLP-1/GIP/Gcg triagonist | long-term potentiation | p-GSK3 beta | OXIDATIVE STRESS | GLYCOGEN-SYNTHASE KINASE-3 | SYNAPTIC PLASTICITY | NEUROSCIENCES | DIABETES-MELLITUS | GLUCAGON-LIKE PEPTIDE-1 | SIGNALING PATHWAY | A-BETA | INDUCED IMPAIRMENT | amyloid-beta (A beta) protein | DEPENDENT INSULINOTROPIC POLYPEPTIDE | RECEPTOR AGONIST | Memory - drug effects | Receptors, Glucagon - agonists | Gene Expression - drug effects | Mice, Inbred C57BL | Cognition Disorders - pathology | Alzheimer Disease - drug therapy | Body Weight - drug effects | Male | Mice, Transgenic | Hippocampus - pathology | Hippocampus - drug effects | Cognition Disorders - drug therapy | Receptors, Gastrointestinal Hormone - agonists | Alzheimer Disease - pathology | Blood Glucose - drug effects | Animals | Neuroprotective Agents - pharmacology | Long-Term Potentiation - drug effects | Glucagon-Like Peptide 1 - agonists | Cognition Disorders - etiology | Female | Alzheimer Disease - psychology | Nootropic Agents - pharmacology | Disease Models, Animal | Genetic engineering | Diabetes | Drug therapy | Alzheimer's disease | Analysis | Potentiation | Neuroprotection | Glucagon | Spatial discrimination | Cognitive ability | Western blotting | Electrophysiological recording | Rodents | Amyloid | Diabetes mellitus (non-insulin dependent) | Neurodegenerative diseases | Diabetes mellitus | Animal memory | Long-term potentiation | Transgenic mice | Cyclic AMP response element-binding protein | Pathology | Molecular modelling | Cognition & reasoning | Tau protein | Alzheimers disease | Immunofluorescence | Short term memory | Hippocampus | Ca2+/calmodulin-dependent protein kinase II | Spatial memory | Index Medicus
Journal Article
Aging Cell, ISSN 1474-9718, 08/2014, Volume 13, Issue 4, pp. 631 - 640
Journal Article
Molecular Neurobiology, ISSN 0893-7648, 9/2017, Volume 54, Issue 7, pp. 5604 - 5619
Journal Article